Video Clips
Quoted moments from Alaska public meetings, hearings, and press conferences.

Glenn Graham
“I think people in the VA by large, at least those that I work with, were dedicated civil servants. They felt that federal service was an honor and a privilege and a duty to veterans. But yet somehow the federal civil servants, even including in the VA, were treated somehow as a public enemy. And that created a hostile work environment that I did not understand.”Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

Glenn Graham
“I was struck by the fact that people who had gone through the entire recruitment process up to basically signing on would sometimes decline jobs. I tried to get a specific percentage of that, it's hard to know. Although one media source said that early in the first part of 2025, there were about 40% of jobs offered to physicians in the VA were declined.”Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

Anchorage Assembly: Assembly Regular - July 21, 2026 · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Mat-Su Borough: Assembly Meeting - July 21. 2026 · Jul 21, 2026

Larry McNeil
“Stanford University recently published a headline that read, and I quote, "AI hiring tools can yield racial bias." and systemic rejection with their hiring. And this was in their human-centered artificial intelligence area. And this was dated May 26, 2026, if you want to, you know, look it up yourself. So, this is bad because so many businesses, schools, governments, and organizations are using AI to evaluate applicants.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“When students are expected to do creative work, you can't use AI to be doing that because you'll get a canned look that looks stale and stereotypical. And because AI doesn't know, you know, the meaning behind what a lot of the artwork is about.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Kelly Monteleone
“What about our form line art, and how is AI a threat to copy or redefine the art form? The artist can manipulate form line by 1/16 of an inch and it matters.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“Write your own material, you know, because in spite of, you know, students or potential students thinking, you know, that they're disguising, you know, their submissions as being authored by them. It's very, very easily recognizable as being written by AI.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“Applications that were easily identifiable as being written by artificial intelligence. No human wrote those submissions, you know. And so we faculty, we didn't know what to make about that, you know, at first going, wait a second, this is about creativity and these students are using AI to write these really critical statements. And that was not okay.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“This points to an ethics weakness that are starting to appear with the usage of AI as a systemic tool, especially when humans are removed from hiring decisions.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“AI is kind of like this drunken car, you know, going 200 miles an hour, you know, down a busy street, and there's no guardrails or very little guardrails. And that's the scary part.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“in the age of artificial intelligence, artists need to be more innovative with making a living as artists. We need to be innovative and reassert the authenticity of our art in the face of AI.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“I witnessed it myself, you know, because I'd sit on committees, you know, as a faculty member, and we'd be evaluating student applications to our programs. And you know what? That's one of the things that I was able to notice because I do a lot of writing. I was able to spot AI, you know?”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“It's balance and AI can't do that. Thank you, Dorothy. Yes, I would totally agree with that. I don't think AI has the ability to really do maybe what we could call is a proper form line. At least I haven't seen it yet.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“I'm going to talk about the artist statement just really briefly. It's what you need to author yourself because authenticity is an important aspect of all of it.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Larry McNeil
“AI artist statements and essays are becoming clones of each other, And if there are 50 openings for students and 50 of the essays are identical, that will stand out as the essays written by a real person will stand out. You'll be able to see it. I mean, I know this from personal experience because I've seen it myself. You know, it wasn't 50 of them. I think we had 37 applicants.”Sealaska Heritage Institute: Lecture: Continue Making a Living as an Artist and Avoid Being Replaced by AI | Sealaska Heritage · Jul 21, 2026

Anchorage Assembly: ACCEE Fund Board Meeting 2026-07-15 Meeting Recording · Jul 21, 2026

Anchorage Assembly: ACCEE Fund Board Meeting 2026-07-15 Meeting Recording · Jul 21, 2026